Latest White Papers and Case Studies

Executive Summary  Cancer care is becoming increasingly complex and personalized. More and more patient characteristics and disease specific data – clinical history, comorbidities, imaging, laboratory data, genomics/ proteomics, lifestyle factors, pathology results – have to be factore

Executive Summary  Value Partnerships™ are the enduring relationships that Siemens Healthineers forges with customers in order to optimize operations, expand capabilities, and advance innovation within healthcare enterprises. One of the areas where optimization can transform care delivery a

The human-centered approach to healthcare facility planning and design. Executive Summary Transforming care delivery through facility design and planning Healthcare environments continue to evolve, with new pressures from patients, staff, and payers driving care providers to be more

Transforming care delivery in a single department or an entire healthcare enterprise. Executive Summary  Digital twin technology has proven its value in manufacturing, where use of connected technology to monitor performance, model processes, and optimize efficiency is already a mains

Smart data integration and decision support along the patient pathway In today’s digitalized healthcare environment, informed medical decision-making increasingly depends on the smart integration of data. However, there are many barriers and challenges along the patient pathway. Complex decision

1 in 5 advanced fibrosis patients evolves to cirrhosis in as little as two and a half years. The liver is the largest gland in the human body and, weighing roughly two kilograms, it is the second largest organ after the skin. Its varied functions include supplying the brain with gluco

Pneumonia can be deadly in a hospital setting. Two main factors contribute to the approximately 20 percent mortality rate of this healthcare-associated infection (HAI). First, whatever condition brought the patient to the hospital in the first place has likely weakened them, making the patient more

HAIs are costly both in terms of harm/mortality and cost. Close attention to aseptic practices and monitoring patients can greatly reduce the incidence of these infections. Central Line-Associated Bloodstream infections (CLABSIs) are the most costly type of hospital-acquired infections, both

In vitro study validating the microbial barrier function by means of airborne contamination Jürgen Gebel, Sapuna Kuriakose, Barbara Grüter, Martin Exner; University of Bonn Hospital, Institute for Hygiene and Public Health, Germany   BACKGROUND Nosocomial infections pose a major p

In vitro study validating the microbial barrier function of closed infusion systems against microbial touch- and airborne contamination  Dr. Jörg Brünke, QualityLabs BT GmbH, 90411 Nuremberg, Germany   BACKGROUND Healthcare-acquired infections (HAIs) are a major problem for h